Search PubMed⌕ Search

Biomedical subjects

Bernardo Rodrigues

Publications and source records attributed to Bernardo Rodrigues.

7 recordsLinked to original sources

Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease?

This study analysed if botulinum toxin type A (BTX-A) decreases drooling in 21 Parkinson's disease patients. BTX-A injections were given in the parotid glands. The severity of drooling decreased in 18 (86%) patients, while frequency was reduced in 8 (38%). In 11(52%) patients, the frequency of drooling remained constant, which may reflect more difficulties in swallowing, compared to the group that presented such improvement. Future trials assessing the level of swallowing dysfunction may be important to establish a prognosis for patients who keep the frequency of drooling in spite of decreased severity after BTX injection.

Aged↗

Clinical and epidemiological profile of multiple sclerosis in a reference center in the State of Bahia, Brazil.

Multiple sclerosis (MS) is an autoimmune, demyelinating and degenerative disease that affects the central nervous system. Its prevalence and clinical aspects vary according to the continent considered, being more frequent in Caucasians and young individuals aged 20 to 40 years. Epidemiological data from Brazil show that prevalence is variable, being more frequent in the Southern and Southeastern areas of the country, rather than in the Northern and Northeastern areas. The purpose of this paper is to describe MS clinical and epidemiological features in the State of Bahia, in the Brazilian Northeastern region. Thus, we held a cross-sectional study over the period from February to May, 2005, in the Multiple Sclerosis Patient Support Center ("Núcleo de Apoio aos Pacientes com Esclerose Múltipla") of Bahia, which included all patients with a diagnosis of MS seen over this period of time. A total of 121 patients were investigated, being 80.2% females (female:male ratio=4:1), with higher frequency in mulatto individuals (64%), and the relapsing-remitting type (91.3%). Most patients (68.7%) had mild MS, and blacks were prone to worse prognosis compared to other patients.

Adolescent↗

Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis.

Muscle over-activity is one of the cardinal features of spasticity and it is a common disability of stroke patients. In this group, spasticity is responsible for several limitations that interfere in their daily activities and quality of life. To treat spasticity, neurologists usually prescribe drugs as baclofen, tizanidine or benzodiazepines or even use definitive treatment as phenol or surgery. Authors suggest the use of botulinum toxin type A (BTX-A) for spasticity in the upper limbs after stroke, but there are few papers with adequate methodology supporting this idea. In this article we summarize the data of previous double-blind, randomised clinical trials to asses, with a meta-analysis, if BTX-A is an adequate treatment for spasticity due to stroke. The results show a statistical superiority of BTX-A ov%r placebo on reducing muscle tone by the Modified Ashworth Scale (WMD= 0.95 [0.74 to 1.17]) in patients with post-stroke upper limb spasticity.

Botulinum Toxins, Type A↗

[Anthropometric cranial measures of normal newborn].

OBJECTIVE: The study has been carried out through anthropometric measures of Bahian newborns, to define measures according with the reality of this region. METHOD: Study type transversal cut in term babies with the measures of cephalic perimeter, biauricular and anteroposterior distances, fontanel and cephalic index. RESULTS: 388 babies, 204 (52.6%) of males and 184 (47.4%) females had been evaluated. The cephalic perimeter varied between 31.0 and 38.0 cm, with 34.4 +/- 1.2 average. The cephalic index varied between 0.75 and 1.06, with 0.91 +/- 0.05 average. CONCLUSION: The anthropometric measures are surveyed aiming at precocious detention of anomalies. Possibly, these measures can be influenced by racial factors; however, the measures carried through in Brazil follow values of foreign authors. Thus, the study shows data of a Northeastern region and points out the importance of the accomplishment of multicentric studies.

Body Weight↗

Prevalence of Chagas' disease in Mulungu do Morro northeastern Brazil.

OBJECTIVE: The aim of this paper is to describe the prevalence of T. Cruzi infection in patients of from Mulungu do Morro, a rural tropical region of Northeastern Brazil. METHODS: A cross-sectional study was performed. After randomly selecting samples of the population, and obtaining their consents, patients completed pretested epidemiological and clinical questionnaires. Serum samples from all patients were collected and screened for the presence of T. cruzi antibodies. RESULTS: Of 694 patients examined, 174 patients (25.1%) tested had a positive serology for Chagas' disease. Of the study population, 341 patients were male with 27% Chagas' disease prevalence, without a statistical difference. Illiteracy was the only variable related to T. cruzi infection in our population. CONCLUSION: In conclusion, our study points to the high prevalence of Chagas' disease among patients in Mulungu do Morro, suggesting that this region has a high frequency of infection and probably active vectorial transmission.

Adolescent↗

[Clinical and laboratory features of aseptic meningitis associated with measles-mumps-rubella vaccine].

OBJECTIVE: To describe epidemiological, clinical, and cerebrospinal fluid (CSF) findings in cases of aseptic meningitis associated with measles-mumps-rubella vaccination following a mass immunization campaign in the Brazilian state of Bahia in August 1997 promoted by the country's Ministry of Health, and to compare these cases to the cases of aseptic meningitis not associated with the vaccine that occurred in the same year. METHODS: Between March 1997 and October 1997, all individuals between 1 and 12 years of age admitted to the Couto Maia Hospital (the Bahia reference hospital for infectious illnesses) with a clinical and laboratory diagnosis of aseptic meningitis were prospectively followed. The study population was divided into two groups: one with individuals who had received the vaccine, and one with individuals who had not received the vaccine. Demographic, clinical, and laboratory information was collected on both groups. RESULTS: In September, following the vaccination campaign, 74 cases of aseptic meningitis were registered at the Couto Maia Hospital, versus the monthly average of 7.5 cases. We observed a greater frequency of nuchal rigidity and increased CSF cellularity among children whose meningitis was associated with the vaccine. However, encephalitic involvement was more frequent in the group of children with non-vaccinal meningitis. CONCLUSIONS: Although the course of post-vaccinal meningitis is more benign than that of other forms of the disease, its treatment generates costs related to ancillary exams and hospitalizations. Mass vaccination campaigns should employ less reactogenic vaccine strains.

Child↗

[Clinical and laboratory aspects of acute bacterial meningitis in infants].

OBJECTIVE: to describe clinical and laboratorial characteristics of acute bacterial meningitis in infants. METHOD: data from the prospective follow-up of infants with acute bacterial meningitis, admitted at the Hospital Couto Maia between March and December 1997, were analyzed with specific statistical software. RESULTS: acute bacterial meningitis was more prevalent in infants with ages varying from 6 months to 1 year. The most frequent etiologic agent was Haemophilus influenzae. The global lethality was 25.9% and among the survivors 39.3% left the hospital with some abnormality in the neurological exam compatible with the brain involvement. CONCLUSION: acute bacterial meningitis in infants is a high lethality disease that in the majority of cases can be prevented. We consider of great relevance the adoption of health prevention strategies in order to reduce the incidence of this disease.

Brazil↗